Capillary technologies India Limited has announced its earnings conference call for the fourth quarter of fiscal year 2025-26, providing investors and analysts an opportunity to engage with management following the release of financial results.

Conference Call Details

The company has scheduled the earnings discussion for May 6, 2026, following the announcement of financial results for the quarter and year ended March 31, 2026. The call will provide stakeholders with insights into the company's performance and strategic direction.

Regulatory Compliance

The announcement was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has duly informed both major stock exchanges about the scheduled investor interaction.

Investor Access

The earnings conference call invitation and related materials will be made available on the company's official website at capillarytech.com/investors/. This ensures transparency and equal access to information for all stakeholders interested in the company's quarterly performance and future outlook.

The call represents a standard practice for listed companies to maintain regular communication with the investment community and provide detailed explanations of financial performance beyond the published results.

Capillary Technologies India Limited has completed the allotment of 64,680 equity shares under its Employee Stock Option Scheme 2021 (ESOP Plan 2021), as announced in a regulatory filing dated April 17, 2026. The allotment represents the exercise of vested stock options by employees under the company's share-based compensation program.

Share Allotment Details

The Nomination and Remuneration Committee of the Board of Directors approved the allotment through a circular resolution on April 16, 2026. The shares were issued in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Impact on Share Capital

Following this ESOP allotment, the company's equity structure has been updated with significant changes to the total issued shares and share capital.

Regulatory Compliance

The company has fulfilled all regulatory requirements under the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The statement under Regulation 10(b) for ESOP Plan 2021 was previously filed with both BSE Limited and National Stock Exchange of India Limited on January 08, 2026, with filing numbers 256643 and 52926 respectively.

Share Characteristics

The newly allotted equity shares are identical in all respects to the existing equity shares of the company and rank pari passu with them. No lock-in provisions apply to these shares, and no listing fees are associated with this allotment. The shares are listed on both the National Stock Exchange of India Limited and BSE Limited.

This ESOP allotment reflects the company's ongoing commitment to employee participation in its equity growth and aligns with standard corporate practices for retaining and incentivizing key personnel through share-based compensation schemes.